Gilead Sciences to Present at Three Upcoming Investor Conferences

- 2009 Morgan Stanley Global Healthcare Unplugged Conference on September 14th -

- ThinkEquity 6th Annual Growth Conference: G6 on September 15th

- Banc of America Merrill Lynch Global Healthcare Conference on September 16th -

- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 11, 2009-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the company will be webcasting its corporate presentation at three upcoming investor conferences: the 2009 Morgan Stanley Global Healthcare Unplugged Conference in New York, the ThinkEquity 6th Annual Growth Conference: G6 in San Francisco and the Banc of America Merrill Lynch Global Healthcare Conference in London.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, along with Kevin Young, Gilead’s Executive Vice President, Commercial Operations, will provide an overview of the company at the Morgan Stanley conference on Monday, September 14 at 9:45 a.m. Eastern Daylight Time (EDT).

Gregg H. Alton, Gilead’s Executive Vice President, Corporate and Medical Affairs, will provide an overview of the company at the ThinkEquity conference on Tuesday, September 15 at 9:30 a.m. Pacific Daylight Time (12:30 p.m. EDT).

Dr. Milligan will provide an overview of the company at the Banc of America Merrill Lynch Global Healthcare Conference on Wednesday, September 16 at 11:20 a.m. British Summer Time (6:20 a.m. EDT).

To access the live webcasts via the internet log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor Relations